Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Gastro-oesophageal reflux disease (GORD) is a common condition relating to the movement of stomach contents into the oesophagus, which can lead to unpleasant symptoms and a broad range of clinical complications. These associated symptoms and complications are highly eclectic and the pathophysiology of GORD is multifactorial, which can make an accurate diagnosis challenging. The current paradigm of GORD diagnosis is not based on specific pathophysiological mechanisms, but rather the severity of reflux seen on endoscopy and physiology testing.
Definition: GORD is defined by the World Gastroenterology Organization as ‘troublesome symptoms sufficient to impair an individual’s quality of life, or injury or complications that result from the retrograde flow of gastric contents into the oesophagus, oropharynx, and/or respiratory tract’. It is the most common oesophageal disorder, yet disease manifestation may go beyond the oesophagus into the ear, nose, throat, mouth, and lungs.
There is a fine distinction between reflux and GORD. The former is a physiological phenomenon that occurs following meals and eructation, but the process whereby reflux results in troublesome symptoms or complications is a nuance of mechanisms relating to the oesophagogastric junction (OGJ), the oesophageal body, and the central nervous system.
The OGJ is the principle antireflux barrier consisting of the lower oesophageal sphincter (LOS) and the crural diaphragm (CD), which are superimposed in health. The smooth muscles of the LOS are semi-circular fibres that form clasps around each other and bridge the gastric sling fibres, whereas the skeletal muscles of the CD form the external part of the antireflux barrier where the oesophagus passes through the right crus of the CD. Both the LOS and CD have an asymmetric pressure profile with inspiration producing a greater increase in OGJ pressure toward the greater curvature of the stomach, and the peak LOS pressure correlates with the maximum muscle thickness found on the greater curve where the gastric sling fibres are most dense.
The CD produces a pinch-cock effect on the LOS, which results in an increase of 10 to 20 mmHg in OGJ pressure during inspiration. A type of biofeedback called diaphragmatic breathing has been shown in randomised controlled studies to augment LOS pressure, improve GORD-related quality-of-life scores, reduce the use of medications, and reduce physiological reflux. ,
Reflux can occur when intragastric pressure exceeds the resting LOS pressure, forcing gastric contents up into the oesophagus. A hypotensive LOS is common in patients with GORD, but paradoxically, a hypertensive LOS in GORD is not uncommon. Therefore, low LOS pressure cannot be the sole mechanism for reflux. When intragastric pressure increases, a ‘yield’ pressure is reached which triggers a transient lower oesophageal sphincter relaxation (TLOSR). This is a normal reflex mediated via vagal afferents, but if this reflex is hypersensitive, yield pressures are reduced and TLOSRs are triggered too frequently and are thought to have a stronger correlation with GORD than hypotensive LOS pressure. Both LOS pressure and TLOSRs can be defined on high-resolution manometry (HRM) where the LOS pressure is < 10 mmHg (software dependant), and TLOSRs are LOS relaxations lasting greater than 10 seconds in the absence of swallowing and are associated with CD inhibition.
TLOSRs are triggered by pharyngeal intubation, meal ingestion, upright posture, smoking, and hyperglycaemia, although the primary trigger for TLOSRs is thought to be gastric distension following meals or aerophagia (excessive air swallowing). Gastric accommodation is the physiological response to gastric distension, which serves to offset a rise in intragastric pressure during meal intake. In patients with GORD and healthy controls, smaller changes in intragastric pressure (i.e. poor gastric accommodation) lead to an overall increased presence of TLSORs. Hence, gastric accommodation likely plays a role in TLOSRs via mechanoreceptor signalling from the gastric wall. Moreover, this may explain why GORD frequently overlaps with conditions related to poor gastric accommodation, namely functional dyspepsia and gastroparesis.
Delayed gastric emptying may contribute to increased TLOSRs since prolonged retention of contents leads to prolonged distension. Other gastric factors include cholecystokinin (CCK), which has been shown to induce a period of partial relaxation followed complete lower oesophageal sphincter (LOS) relaxation along with CD inhibition. When nutrients enter the duodenum, CCK is released and prevents further emptying of the stomach. It should be noted that TLOSRs do have a physiological purpose, to allow gas venting from the stomach, whether that gas is ingested from air swallowing or carbonated drinks, or created by fermentation in the gut: excessive fermentation of poorly digested carbohydrates in the colon is associated with increased TLOSRs.
The OGJ antireflux barrier may become jeopardized following separation of the LOS and CD, resulting in a hiatal hernia (HH). This is a fundamental finding in GORD, and HH is associated with the presence and severity of oesophagitis, increased oesophageal acid exposure, and reflux episodes, but not increased TLSORs. Instead, reflux episodes are increased during periods with low LOS pressure, straining, swallowing, and deep inspiration, which highlights the importance of the CD in protection against reflux. Impaired CD function can be assessed on HRM by inspiratory augmentation of OGJ pressure, and one study found that 37 out of 39 subjects with inspiratory augmentations of OGJ ≤ 0 mmHg had objectively pathological GORD. This was the strongest predictor of GORD, even more so than LOS pressure and LOS-CD separation.
The prevalence of a HH is associated with increased age but the aetiology remains unclear. It is thought that repetitive elevation of intragastric pressure may force the hiatus upwards, or alternatively, age-associated myopathy may play a role. HHs are seen in up to 40% of obese individuals, which supports the theory of increased gastric pressure. Furthermore, bariatric surgery can lead to increased intragastric pressure, namely sleeve gastrectomy and gastric band, for which worsening or new-onset GORD is more common compared to Roux-en-Y bypass.
A HH can also promote reflux via an acid pocket where part of the stomach is positioned above the diaphragm. This stomach portion generates acid, particularly following meals, which can then pool and reflux more easily into the oesophagus. Healthy controls were shown to also have an unbuffered acidic segment in the proximal stomach; however, this is typically below the squamocolumnar junction (SCJ) whereas the acid pocket in patients with GORD and HH lies above the diaphragm.
Defects in peristalsis may lead to impaired clearance of gastric refluxate and prolonged acid exposure. Indeed, hypomotility is common in GORD, but the cause and effect as to whether reflux causes hypomotility or vice versa is uncertain. Fundamentally, oesophageal peristalsis is required to counteract refluxate and this can be primary (swallow induced) or secondary (triggered by distension). Reflux elicits distension of the oesophageal lumen via activation of stretch receptors in the oesophageal wall, which triggers secondary peristalsis and volume clearance. However, this is not sufficient to neutralise acid. On the other hand, swallow-induced primary peristalsis contains bicarbonate saliva necessary to achieve chemical clearance and pH normalisation.
The traditional paradigm of GORD complications is that acid directly erodes the oesophageal mucosa leading to inflammation, oesophagitis, and more rarely, dysplasia. Noxious refluxate containing acid, pepsin, and bile salts is thought to damage the tight junction proteins between cells, such as claudins, occludins, and E-cadherin. This leads to greater diametric separation between cells known as dilated intercellular spaces (DISs). DISs are seen in up to 100% of patients with erosive oesophagitis and up to 83% of patients with non-erosive reflux disease (NERD), and DISs reduce following proton pump inhibitor (PPI) therapy. However, up to 30% of healthy controls have DISs as well as patients with NERD who are refractory to PPI. Persistence of DISs may be consequent to bile acid or, indirectly, animal studies have shown that psychological stress induces DISs.
Overall, DISs appear to reflect reflux burden, but immune response presents an alternative paradigm for complications of GORD. This was first proposed by Souza and colleagues, who demonstrated in an in vitro model that oesophagitis developed several days after acidified bile salt exposure. Initial exposure triggered the increased presence of proinflammatory cytokines (interleukin-8 and interleukin-1β) that signal migration of T cells and neutrophils into the submucosa, which eventually progressed to the epithelial surface. More recently, biopsies from patients who discontinued PPIs 2 weeks before endoscopy showed T lymphocyte infiltration in areas without surface erosions. Furthermore, in patients with reflux oesophagitis, biopsies showed increased hypoxia-inducible factor 2a, a proinflammatory cytokine that is induced by bile salts.
Barrett’s oesophagus (BO) relates to the histological change from normal stratified squamous epithelium lining the oesophagus to a metaplastic columnar epithelium with goblet cells, typically more reflective of the duodenum than the stomach. , BO is thought to be an intermediate step between oesophagitis and oesophageal adenocarcinoma (OAC), and is more common in GORD than the general population. The risk of BO progressing to OAC is significantly reduced with adequate PPI therapy, which demonstrates the pathophysiology of gastric acid in BO progression, but there are likely immunological mechanisms akin to reflux oesophagitis. While these mechanisms remain unclear, FoxP3 , a gene associated with poor prognosis for oesophageal cancer, is greatly expressed in BO. ,
The means by which reflux triggers symptoms is still not well understood and highly paradoxical. First, patients with BO often report fewer symptoms compared to patients with no objective evidence of reflux. Second, symptoms respond variably to acid-suppression medications, which suggests other mechanisms than gastric acid alone. Indeed, pain receptors called transient receptor potential vanilloid-1 (TRPV1), present in oesophageal sensory afferents, are activated in response to several stimuli including heat, low pH, protons, lipid derivatives, and the principle compound in chilli peppers, capsaicin. In one study, researchers injected the oesophageal submucosa of healthy volunteers with acid and capsaicin, which only capsaicin triggered severe sensations of heartburn and chest pain. Patients will often report that spicy foods cause reflux, but capsaicin has not been shown to induce LOS dysfunction nor increase TLOSRs. Rather, enhanced symptom perception is likely due to direct effects on oesophageal sensation. TRPV1 may be the primary afferent pathway for reflux symptoms since it is upregulated in patients with erosive oesophagitis and NERD. Evidence to support this was objectively demonstrated in a study by Hobson et al. that showed that oesophageal afferent pathway sensitivity negatively correlated with acid exposure in NERD patients, meaning that equivalent symptoms could be generated by lower levels of acid exposure dependent on the sensitivity of oesophageal afferent nerves.
The advent of pH-impedance monitoring has revealed that symptom perception is multifactorial owing to acidity, composition (liquid, gas, or mixed), impaired reflux bolus clearance, and the proximal extent or volume of reflux. In NERD patients, spontaneous acid reflux enhances subsequent reflux perception regardless of activity or composition. Clearly, sensitization of the oesophagus from acidic and weakly acidic events primes the oesophagus. Additionally, mental fatigue may play a fundamental role in perception. Schey and colleagues showed that sleep deprivation led to heightened sensitivity and a greater intensity response to oesophageal acid exposure.
Defining GORD epidemiology is not straightforward because symptoms are entirely subjective and objective evidence of GORD is seldom reported in epidemiological studies, which makes understanding the true impact of GORD challenging.
According to a systematic review published in 2020, the pooled prevalence of GORD in the UK was 14.53% and the economic cost is approximately £760 million/year, whereas the US was 21.04% and an estimated $24 billion/year. GORD is a significant health and financial burden that will continue to escalate, since the all-age prevalence of GORD increased by 18.1% between 1990 and 2017, while in the same time frame, years lived with disability related to GORD increased by 67.1%, reflecting the increased prevalence in older age groups and a generally ageing population. A systematic review from 2014 found that the adult incidence was approximately 5 per 1000 person-years in the UK and USA, but the overall incidence was 0.84 per 1000 person-years for paediatrics in the UK, which further reflects the adult-onset nature of GORD. Indeed, age is one of the strongest predictors for GORD, with a lower prevalence in 18–34 years (8.70%) versus 35–59 years (14.53%; odds ratio [OR] 1.17 and relative risk [RR] 1.15) and ≥ 60 years (13.12%; OR 1.20 and RR 1.17).
Obesity is another strong risk factor for GORD, with an OR around 1.7 for a body mass index (BMI) ≥ 30. , Increased abdominal pressure plays a significant role in the pathophysiology of GORD in obese patients. Other risk factors for GORD include low education level, urban habitation, and nonsteroidal anti-inflammatory drug (NSAID) use, but not alcohol intake or smoking. A review from 2018 confirmed that GORD prevalence is not significantly different between alcohol and non-alcohol users. However, in this study, smoking had an OR of 1.26 compared to non-smokers. Typically, smokers will make poorer lifestyle choices, but it is thought that reflux is induced by deep inspiration and coughing. In any case, patients who report smoking should be encouraged to quit since it is strongly associated with OAC independent of GORD.
Interestingly, according to marital status, the prevalence of GORD in divorced/separated/widowed individuals was significantly greater than single individuals (22.95% vs 12.85%, respectively), which suggests a contributory role for emotional stress in GORD. Data on the effect of diet, food, and drink are somewhat limited, but those with moderate/high intake of carbonated drinks had greater risk (OR 1.29 and RR 1.24), which may be attributed to the gas-provoked mechanism of refluxate. Also, moderate/high intake of coffee/tea was associated with greater risk (OR 1.47 and RR 1.38), which may be consequent to caffeine-induced oesophageal dysfunction, resulting in a decrease in basal LOS pressure and distal oesophageal contraction.
The GBD 2017 Gastro-oesophageal Reflux Disease Collaborators used data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to assess the global burden of GORD. The age-standardised prevalence was highest (> 11,000 cases per 100,000 population) in the USA, Middle East, North Africa, Eastern Europe, and several Latin America countries, while it was lowest (< 7000 cases per 100,000 population) in East Asia and several European countries. Overall, the global age-standardised prevalence of GORD was relatively stable between 1990 and 2017. However, the all-age prevalence of GORD increased by 18.1% and years lived with disabilities related to GORD increased by 67.1%, which suggests that the global burden of GORD will continue to escalate along with an ageing and expanding population.
Typical GORD symptoms (i.e. heartburn and regurgitation) respond better to medical and surgical treatment than atypical symptoms, which emphasises the value of a good clinical history. According to the Montreal Consensus, atypical symptoms include non-cardiac chest pain and extraoesophageal symptoms; i.e. laryngeal or pulmonary complaints, although chest pain, discomfort, and burning may be indistinguishable to some patients. In any case, an empiric trial of PPI therapy is often the first step, but up to 40% of patients will experience persistent symptoms despite PPI use. In addition, a large proportion of these patients do not demonstrate conclusive evidence of GORD on endoscopy or pH monitoring. ,
When compared to endoscopy and pH monitoring, expert history by a gastroenterologist has only a sensitivity and specificity of 70% and 67%, respectively. Questionnaires share similarly limited sensitivity and specificity of 62% and 67% for the Reflux Disease Questionnaire (RDQ), and 65% and 71% for the GerdQ, respectively. Trial with PPIs is even more limited with a sensitivity of 71% and specificity of 44%, , yet PPI trials are cheap, pragmatic, and recommended by societal guidelines. This has undoubtedly led to the overuse of PPIs, which although they appear to be safe, may have detrimental consequences to the gut microbiome. , Ultimately, history, questionnaires, and PPI trials are of limited value in the diagnosis of GORD, highlighting the need for further investigation in most cases.
There is a contretemps over PPI use based on several large observational studies that showed an association between PPIs and medical complications – including death. However, a large observational study in 1.9 million US seniors found that PPI use is not associated with increased risk after accounting for comorbidities and protopathic bias; for example, a patient starts PPI for cough but dies from pneumonia. The only clear complication from PPI use is changes to the gut microbiota to one that is predisposed to enteric infections and populated with oropharyngeal flora. , The effects of PPI on the microbiome are more prominent than the effects of antibiotics or other commonly used drugs.
Upper endoscopy (OGD) is advised when symptoms of GORD do not respond to empiric PPI therapy, or if there are concomitant alarm symptoms including dysphagia, unexplained weight loss, and persistent vomiting.
The Lyon Consensus was published in 2018 to standardise the objective diagnosis of GORD. Conclusive evidence for GORD requires high-grade erosive oesophagitis (LA grades C and D), long-segment Barrett’s mucosa, or peptic strictures on endoscopy or distal oesophageal acid exposure time (AET) > 6% on ambulatory pH monitoring. Alternatively, GORD can be excluded if endoscopy is normal, distal AET is < 4% and < 40 reflux episodes on pH-impedance monitoring off PPI therapy. Of note, there is no recommendation for the use of DeMeester score in the diagnosis of GORD.
However, erosive oesophagitis is found in fewer than 10% of patients already taking PPIs. In addition, oesophagitis is typically low grade, and with significant interobserver variability, pH-metry evidence of GORD is most often required prior to antireflux surgery. Overall, endoscopy has a low sensitivity in GORD diagnosis.
OGD should also exclude eosinophilic oesophagitis (EoE), as well as heterotopic gastric mucosa within the cervical oesophagus, also known as an inlet patch. The prevalence of an inlet patch is approximately 3% in those undergoing OGD. While the clinical significance remains unclear, studies have shown that ablation therapy may result in improvement of laryngopharyngeal reflux (LPR) symptoms. ,
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here